Full metadata record
DC FieldValueLanguage
dc.contributor.authorHengartner, Michael P.-
dc.date.accessioned2022-01-07T13:07:00Z-
dc.date.available2022-01-07T13:07:00Z-
dc.date.issued2021-12-
dc.identifier.isbn978-3-030-82586-7de_CH
dc.identifier.isbn978-3-030-82587-4de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/23859-
dc.description.abstractThis book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms. The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroborating the overemphasis on drug treatment in both research and practice. Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.de_CH
dc.format.extentVII, 354de_CH
dc.language.isoende_CH
dc.publisherPalgrave Macmillande_CH
dc.rightsLicence according to publishing contractde_CH
dc.subjectAntidepressantde_CH
dc.subjectEvidence-based medicinede_CH
dc.subjectMedical-industrial complexde_CH
dc.subjectPsychopharmacologyde_CH
dc.subjectMethod biasde_CH
dc.subjectDepressionde_CH
dc.subjectMedication for depressionde_CH
dc.subjectPharmaceutical industryde_CH
dc.subjectLong-term harms of antidepressantsde_CH
dc.subject.ddc615: Pharmakologie und Therapeutikde_CH
dc.subject.ddc616.8: Neurologie und Krankheiten des Nervensystemsde_CH
dc.titleEvidence-biased antidepressant prescription : overmedicalisation, flawed research, and conflicts of interestde_CH
dc.typeBuchde_CH
dcterms.typeTextde_CH
zhaw.departementAngewandte Psychologiede_CH
zhaw.organisationalunitPsychologisches Institut (PI)de_CH
zhaw.publisher.placeLondonde_CH
dc.identifier.doi10.1007/978-3-030-82587-4de_CH
zhaw.funding.euNode_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.publication.reviewEditorial reviewde_CH
zhaw.webfeedKlinische Psychologiede_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Angewandte Psychologie

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.